A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2011
11/29/2011	US8066971 Targeting pulmonary epithelium using ADRP
11/29/2011	US8066970 Contrast agents
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2456327C Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/24/2011	WO2011144744A1 Targeted radioactive compound for human cd66 for the treatment of disorders
11/24/2011	WO2011092295A3 Radioimmunoconjugates and uses thereof
11/24/2011	US20110286922 Imaging and radiotherapy methods
11/24/2011	US20110286921 18f-labelled folates as pet radiotracers
11/24/2011	US20110286920 Complex of bifunctional chelating agent and mannosyl human serum albumin
11/24/2011	US20110286919 Conjugates of noscapine and folic acid and their use in treating cancer
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	US20110286917 Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer
11/24/2011	US20110286916 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
11/24/2011	US20110286915 Nanocarriers for Drug Delivery
11/23/2011	EP2388264A1 Compound retained in tumor
11/23/2011	EP2388017A2 Catalytic radiofluorination
11/23/2011	EP1749026B1 Labelled adrenomedullin derivatives and their use for imaging and therapy
11/23/2011	EP1644941B1 Method of manufacturing magnetic nanoparticles having improved magnetic properties
11/23/2011	CN1897978B Assembly of gas-filled microvesicle with active component for contrast imaging
11/23/2011	CN102250920A Soluble and mutational BAFF protein and its coding gene and application
11/23/2011	CN101563041B A system for planning combined therapy
11/22/2011	US8063014 Self-assembly of peptide-amphiphile nanofibers under physiological conditions
11/22/2011	US8062673 Process for embolization using swellable and deformable microspheres
11/22/2011	US8062636 Antibody therapy
11/22/2011	CA2515088C Methods for the purification of stable radioiodine conjugates
11/22/2011	CA2258518C Recognition molecules interacting specifically with the active site or cleft of a target molecule
11/17/2011	WO2011143562A2 Il-1 binding proteins
11/17/2011	WO2011143360A2 Compositions, methods and systems for the synthesis and use of imaging agents
11/17/2011	WO2011143128A2 Multi-phasic nanostructures for imaging and therapy
11/17/2011	WO2011141515A1 Diagnostic agents for amyloid beta imaging
11/17/2011	WO2011060104A3 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
11/17/2011	US20110280947 Embolization
11/17/2011	US20110280804 Highly selective sigma receptor radioligands
11/17/2011	US20110280803 Radioiodination method
11/17/2011	US20110280802 Linkers For Radiopharmaceutical Compounds
11/17/2011	US20110280801 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	US20110280799 Nanocells for diagnosis and treatment of diseases and disorders
11/17/2011	US20110280798 Cell Penetrating Peptides for Intracellular Delivery
11/17/2011	CA2799046A1 Il-1 binding proteins
11/16/2011	EP2386576A1 Tumor-specific recognition molecules
11/16/2011	EP2386562A1 Halogen-substituted saccharide, method for producing same, reaction composition of same and device for producing same
11/16/2011	EP2386556A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands
11/15/2011	US8058311 Imaging 18F or 11C-labelled alkylthiophenyl guanidines
11/15/2011	US8058267 Steroids as agonists for FXR
11/15/2011	US8058256 Polymeric carrier for delivery of small interfering RNA
11/15/2011	US8058226 a mixture of antihemophilic factor, bulking agent selected from mannitol, glycine and alanine, stabilizer agents selected from sucrose, trehalose, raffinose and arginine, calcium chloride, sodium chloride and buffers, having storage stability
11/15/2011	US8057827 Chemoablation of tissue using biodegradable, solid salt dosage forms
11/15/2011	US8057799 ErbB interface peptidomimetics and methods of use thereof
11/15/2011	US8057418 Devices and methods for extracorporeal ablation of circulating cells
11/15/2011	CA2476166C Anti-cd20 antibodies and fusion proteins thereof and methods of use
11/15/2011	CA2410387C Polymerizable compositions and methods of use
11/15/2011	CA2257851C Modulators of tissue regeneration
11/10/2011	WO2011140517A2 Methods for treating diseases of the lung
11/10/2011	WO2011140478A2 Compositions and methods for detecting acetylated sumo proteins
11/10/2011	WO2011084571A3 Azide derivatives for phototherapy
11/10/2011	WO2011015958A3 Oncology therapies employing radioactive seeds
11/10/2011	US20110274619 Brain tumor targeting peptides and methods
11/10/2011	US20110274618 Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof
11/10/2011	US20110274617 Antibody-Targeted Carrier For Contrast Agents
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/09/2011	EP2193115B1 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method
11/09/2011	CN1921893B Catalytic radiofluorination
11/09/2011	CN102233140A Chemical composition for radiation and chemotherapy
11/09/2011	CN102233138A Chemical composition for target imaging
11/09/2011	CN101282746B Automated radiolabelling method
11/08/2011	US8055329 Ingestible device for radioimaging of the gastrointestinal tract
11/08/2011	US8053427 Brimonidine gel composition
11/08/2011	US8052669 Methods and devices for delivery of compositions to conduits
11/08/2011	CA2436180C Immunoregulatory antibodies and uses thereof
11/08/2011	CA2153692C Recombinant anti-vla4 antibody molecules
11/03/2011	WO2011135101A2 Ultrafine nanoparticles comprising a functionalized polyorganosiloxane matrix and including metal complexes; method for obtaining same and uses thereof in medical imaging and/or therapy
11/03/2011	WO2011134672A1 Isotope production method
11/03/2011	WO2011134671A1 Isotope preparation method
11/03/2011	WO2011134060A1 Anti-icam-1 single domain antibody and uses thereof
11/03/2011	WO2011033120A3 Method for obtaining 68ga
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110269943 Radiolabeled annexins
11/03/2011	US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011	US20110268657 Compositions and methods for the treatment of tumor of hematopoietic origin
11/03/2011	US20110268656 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
11/03/2011	US20110268655 Anti-alpha v immunoliposome compositions, methods and uses
11/03/2011	US20110268654 Compositions and methods for delivering a substance to a biological target
11/03/2011	US20110268653 Compositions and Methods Related to Acid Stable Lipid Nanospheres
11/03/2011	CA2800565A1 Anti-icam-1 single domain antibody and uses thereof
11/02/2011	EP2383258A1 Method for rapidly methylating heteroaromatic ring aryl and method for producing pet tracer
11/02/2011	EP2382229A2 CYSTEINE-FREE TECHNETIUM (Tc) OR RHENIUM (Re) CHELATING PEPTIDE TAGS AND THEIR USE
11/02/2011	EP2382185A1 Radioiodination method
11/02/2011	EP2381967A1 Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
11/02/2011	EP2381966A2 Pdgf-r binders
11/02/2011	EP1503805B1 Lyophilized edible food incorporating a marker
11/02/2011	CN102232067A Nicotinamide derivatives
11/02/2011	CN102231991A Active particles for bio-analytical applications and methods for their preparation
11/02/2011	CN101015703B Antisense imaging agent and antisense oligonucleotide thereof
11/01/2011	US8048906 Optically pure and enriched isomers of chelating ligands and contrast agents
11/01/2011	US8048846 Topical hair treatment to reduce damage caused by flexure and/or abrasion
11/01/2011	US8048844 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2011	CA2499825C Radiolabeled neurokinin-1 receptor antagonists
11/01/2011	CA2450231C System and method for the large scale labeling of compounds with radiohalogens

1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 243